La Trobe

Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

journal contribution
posted on 2025-02-19, 23:57 authored by Walter FairlieWalter Fairlie, Erinna LeeErinna Lee
B-Cell Lymphoma 2 (BCL-2), c-MYC and related proteins are arguably amongst the most widely studied in all of biology. Every year there are thousands of papers reporting on different aspects of their biochemistry, cellular and physiological mechanisms and functions. This plethora of literature can be attributed to both proteins playing essential roles in the normal functioning of a cell, and by extension a whole organism, but also due to their central role in disease, most notably, cancer. Many cancers arise due to genetic lesions resulting in deregulation of both proteins, and indeed the development and survival of tumours is often dependent on co-operativity between these protein families. In this review we will discuss the individual roles of both proteins in cancer, describe cancers where co-operativity between them has been well-characterised and finally, some strategies to target these proteins therapeutically.

Funding

This research was funded by the Victorian Cancer Agency Mid-Career Research Fellowhip, MCRF19045 (to EFL), and the National Health and Medical Research Council of Australia Project Grants, GNT1122829 and GNT1157551 (to WDF).

History

Publication Date

2021-03-11

Journal

International Journal of Molecular Sciences

Volume

22

Issue

6

Article Number

2841

Pagination

28p.

Publisher

MDPI

ISSN

1661-6596

Rights Statement

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC